Standard Growth Curves in Prader-Willi Syndrome in Japan

Size: px
Start display at page:

Download "Standard Growth Curves in Prader-Willi Syndrome in Japan"

Transcription

1 Clin Pediatr Endocrinol 1993;2 (1): Copyright (C)1993 by The Japanese Society for Pediatric End ocrinology Standard Growth Curves in Prader-Willi Syndrome in Japan Toshiro Nagai, Yutaka Tsuchiya, Yoshimitsu Fukushima, Hidefumi Tonoki, Norio Niikawa and Nobutake Matsuo Department of Pediatrics, Tokyo Metropolitan Kiyose Children's Hospital (T.N., Y.T),D epartment of Pediatrics, Keio University School of Medicine (T.N, N.M.), Tokyo,D epartment of Medical Genetics, Saitama Children's Medical Center, Saitama (Y.E.), Department of Pediatrics, Hokkaido University School of Medicine, Hokkaido (H.T.), Department of Human Genetics, Nagasaki University School of Medicine, Nagasaki (N.N.), Japan Abstract. We report standard growth curves in Japanese Prader -Willi syndrome (PWS) for height. Growth patterns for height are quite different between PWS and normal controls, showing the mean height in PWS ranging at -2SD of normal control data until pubertal age and dropping off far below -2SD of normal control after puberty. These data indicate that the pathogenesis of the short stature of PWS originates from both chromosomal abnormalities and hypogonadism. In addition to these factors we suspect that bone dysplasia seen in patients with this syndrome is also one of the factors in the short stature of PWS. Key words: Prader-Willi syndrome, growth curves, short stature, bone dysplasia, hypogonadism Introduction The Prader-Willi syndrome (PWS) consisting of craniofacial anomalies, infantile hypotonia, hypopigmented skin, hypogonadism, abnormal eating habits, mental retardation, obesity, short stature, and small hands and feet was originally reported in 1956 by Prader, Labhart and Willi [1]. The exact cause of this syndrome is still obscure, but Received: January 25, 1993 Accepted: April 9, 1993 Correspondence: Toshiro Nagai, M.D., Department of Pediatrics, Tokyo Metropolitan Kiyose Children's Hospital, Umezono, Kiyose, Tokyo 204 Japan previous cytogenetic studies have shown that a half or more of patients have microdeletion at the 15q11-q12 region [2]. The parental origin of the del (15) in this syndrome is preferentially paternal in origin [3, 4], strongly suggesting a role for genetic imprinting in expression of PWS phenotype. In addition, karyotypically normal PWS patients sometimes demonstrate both of their normal homologous chromosomes 15 are of maternal origin [5]. The frequency of maternal hetero-disomy is suspected to be around 20% of all PWS [6], indicating that more than 70% of PWS originates from chromosomal abnormalities. There have been a few anthropometric studies in PWS [7-10] and there has not been 39

2 40 NAGAI et al. Vol.2/No.1 reported any significant difference in anthropometric data between individuals with and without 15q deletion [2, 10, 11]. Recently, Butler et al. reported the standards for selected anthropometric measurements including linear growth and weight in Caucasian PWS [12]. In this paper, we report standardized curves for Japanese PWS patients for length and height. Subjects and Methods We studied 84 Japanese patients (ages 1-16 years, 54 males and 30 females) who were clinically diagnosed as PWS, showing infantile hypotonia and feeding difficulty, hypogenitalism, hypopigmented skin, psychomotor retardation, early childhood obesity, and small hands and feet. Approximately one third of the patients were on a calorierestricted diet at the time of the examination. Longitudinal data of length or height were collected on all individuals for a mean period of 7.3 years for males and 6.1 years for females. High resolution chromosome analysis was performed on 76 patients. Forty-eight subjects had chromosomal abnormalities, including 45 subjects with del (15) (q11.1q12), 2 with 45,t (15:15)(p11.1;q11), and 1 with del (15)(q11. 1q12)+inv dup(15)(q11.2;q11.2). Twentyeight subjects had normal karyotypes, but 2 subjects showed maternal heterodisomy. The length and height data collected in a longitudinal mode were arranged to obtain height at each month of age in each case by following the mathematic method, instead of the graphic method, using a growth curve drawn by an eye-fitting technique. This method is the same as Suwa used when he described the standard curves of Japanese Turner's syndrome [13]. When YA and YB are the height at the time (age in months) of XA and XB respectively, the height at Xt between XA and XB is interpolated by the following formula, so long as the interval of the two points of age is within 48 months.yt=[log(xt+1) ~(YA- YB)+log(XB+1) ~YA-log(XA+1) ~YB] [log(xb+1) -log(xa+1)]. Yt at each month of age between XA and XB was calculated. In order to smooth these data, Yt was corrected by the method of "moving mean" averaging the calculated height at 13 points between six months before and after the age of Xt(Yt Yt-5, c cyt-1, Yt+1, c cyt+5, c cyt-1-6). Their longitudinal data of length and height were plotted on our cross-sectional growth curves of Japanese children [14]. Results The mean height at each month of age from birth through 16 years was calculated in the groups with normal and aberrant karyotype (data are not shown here). There was no significant difference between the two groups. Figures 1 through 4 show standardized curves of anthropometric variables for male and female patients with PWS and for healthy individuals. Figures 1 and 2 are the curves from 0 through 48 months (four years) of age and figure 3 and 4 are from 0 through 192 months (16 years) of age, respectively. For the male until four years old, the mean length and height closely approximates the normal- 2SD (Fig. 1), and by 13 years of age, the mean height falls below the normal -2SD and continues to drop off relative to the normal curve (Fig. 3). Similarly, in female patients with PWS, the mean length or height ranges the 2SD of normal control (Fig -6,. 2), and by - 10 years old, the mean height falls below the normal -2SD and continues to drop (Fig Discussion. 4). Standardized curves were produced for length and height for both male and female patients with PWS. Several authors have reported that there is no significant difference

3 June Growth Curves in Prader-Willi Syndrome Fig 1. Longitudinal growth data from 0 to 48 months of age for 54 male patients with PWS plotted Fig 3. Longitudinal growth data from 0 to 16 years of age for 54 male patients with PWS plotted Fig 2. Longitudinal growth data from 0 to 48 months of age for 30 female patients with PWS plotted Fig 4. Longitudinal growth data from 0 to 16 years of age for 30 female patients with PWS plotted in anthropometric data between individuals with and without chromosomal aberrations [2, 10, 11]. We came to the same conclusion. The mean length or height of the individuals with PWS approximates around the nor- mal-2sd until prepubertal age, indicating that the pathogenesis of the short stature of PWS comes from genetic factor(s). The falloff in linear growth occurs after 13 years of age in male and after 10 years of age in female

4 42 NAGAI et al. Vol.2/No.1 Fig 5. The growth data of a patient with PWS treated with growth hormone are plotted on normal Japanese female standard curves. patients, probably reflecting the lack of pubertal growth spurt in patients with PWS. In addition to the above factors as the pathogenesis of the shortness in PWS, we speculate one more factor, a bone dysplasia. We often observe mild bone dysplasia in individuals with PWS and there are also a few reports describing bone abnormalities [15]. Similarly, mild bone dysplasia is known in Turner's syndrome and is suspected to be one of the causal factors of short stature in Turner's syndrome. Anthropometric standards have been developed for several syndromes and have been used successfully in the medical management of patients. There is recent evidence for growth hormone deficiency at least in some patients with PWS and favorable responses to growth hormone therapy [16]. The use of our anthropometric standards may be helpful in those patients who have PWS being treated with growth hormone. We show one female patient with PWS treated with growth hormone and plotted her growth record on the standard growth curves of the normal female (Fig. 5). It is difficult to identify whether this treatment is successful or not, however, when we plot her data on PWS specific growth curves (Fig. 6) the therapeutic usefulness is apparent. Finally in this work we tried to make standard growth curves with PWS, but the number of the older children with this syndrome was not enough to draw perfect growth curves. We would like to improve these growth curves by collecting more data on older patients with PWS in the future. References Fig 6. The growth data of a patient with PWS treated with growth hormone are plotted on PWS specific growth curves. 1. Prader A, Labhart A, Willi H. Ein syndrome von Adipositas, Kleinwuchs, Kryptochismus und Oligophrenie nach myatonieartigem Zustand in Neugeborenenalter. Schweiz Med Wochenschr 1956; 86: Butler MG, Meaney FJ, Palmer CG. Clini-

5 June Growth Curves in Prader-Willi Syndrome cal and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet 1986; 23: Butler MG, Palmer CG. Parental origin in chromosome 15 deletion in Prader-Willi syndrome. Lancet 1983; 1: Mattei JF, Mattei MG, Giraud F. Prader- Willi syndrome and chromosome 15. Hum Genet 1983; 64: Nicholls RD, Knoll KM, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature (London) 1989b; 342: Masgari MJ, Gottlieb W, Rogan P, et al. The frequency of uniparental disomy in Prader-Willi syndrome. N Eng J Med 1992; 326: Bray GA, Dahms WT, Swerdloff RS, Atkinson RL, Carrel RE. The Prader-Willi syndrome. Medicine 1983; 62: Butler MG, Haynes JL, Meaney FJ. Anthropometric study with emphasis on hand and foot measurements in the Prader-Willi syndrome: sex, age, and chromosome effects. Clin Genet 1991; 39: Holm VA, Nugent JK. Growth in the Prader-Willi syndrome. Birth Defects Orig Artic Ser 1982; 18: Butler MG, Meaney FJ. An anthropometric study of 38 individuals with Prader- Labhart-Willi syndrome. Am J Med Genet 1987; 26: Meaney FJ, Butler MG. The developing role of anthropologists in medical genetics: anthropometric measurement of the Prader-Labhart-Willi syndrome as an illustration. Med Anthropol 1989; 10: Butler MG, Meaney FJ. Standards of selected anthropometric measurements in Prader-Willi syndrome. Pediatr 1991; 88: Suwa S. Standards for growth and growth velocity in Turner's syndrome. Acta Paediatr Jpn 1992; 34: Tsuzaki S, Matsuo N, Osano M. The physical growth of Japanese children from birth to 18 years of age: cross sectional percentile growth curves from height and weight. Helvetica Paediatrica Acta 1987; 42: Pagnan NAB, Gollop TR. Prader-Willi habitus, osteopenia, and camptodactyly (Urban-Rogers-Meyer-syndrome). Am J Med Genet 1988; 31: Lee PDK, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG. Linear growth response to exogenous growth hormone in Prader- Willi syndrome. Am J Med Genet 1987; 28:

HHS Public Access Author manuscript Am J Med Genet. Author manuscript; available in PMC 2017 June 23.

HHS Public Access Author manuscript Am J Med Genet. Author manuscript; available in PMC 2017 June 23. An Anthropometric Study of 38 Individuals With Prader-Labhart- Willi Syndrome Merlin G. Butler and Division of Genetics, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee

More information

Body Composition and Fatness Patterns in Prader-Willi Syndrome: Comparison with Simple Obesity

Body Composition and Fatness Patterns in Prader-Willi Syndrome: Comparison with Simple Obesity Original Research as Short Communication Body Composition and Fatness Patterns in Prader-Willi Syndrome: Comparison with Simple Obesity Mariana F. Theodoro, Zohreh Talebizadeh, and Merlin G. Butler Abstract

More information

Insulin resistance and obesity-related factors in Prader Willi syndrome: Comparison with obese subjects

Insulin resistance and obesity-related factors in Prader Willi syndrome: Comparison with obese subjects Clin Genet 24: 67: 23 239. Copyright # Blackwell Munksgaard 24 Printed in Singapore. All rights reserved CLINICAL GENETICS doi: 1.1111/j.1399-4.24.392.x Original Article Insulin resistance and obesity-related

More information

Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only. Non-Preferred Growth Hormone Products

Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only. Non-Preferred Growth Hormone Products Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only Criteria: P0078 Approved: 3/2017 Reviewed: Non-Preferred Growth Hormone Products Complete/review information, sign

More information

Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome

Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome Merlin G. Butler, MD, PhD a, Jaehoon Lee, PhD b, Ann M. Manzardo, PhD a, June-Anne Gold, MD c, Jennifer L. Miller, MD d, Virginia Kimonis,

More information

When to suspect Prader Willi Syndrome and how to diagnose it?

When to suspect Prader Willi Syndrome and how to diagnose it? When to suspect Prader Willi Syndrome and how to diagnose it? Dr Chirita-Emandi Adela Dr Dobrescu Andreea Victor Babes University of Medicine and Pahrmacy Timisoara Emergency Hospital for Children Louis

More information

Prader-Willi Syndrome Urs Eiholzer, Claudia Katschnig, Annik Hauri-Hohl Paediatric Endocrine Center Zurich (PEZZ), Zurich, Switzerland

Prader-Willi Syndrome Urs Eiholzer, Claudia Katschnig, Annik Hauri-Hohl Paediatric Endocrine Center Zurich (PEZZ), Zurich, Switzerland Prader-Willi Syndrome Urs Eiholzer, Claudia Katschnig, Annik Hauri-Hohl Paediatric Endocrine Center Zurich (PEZZ), Zurich, Switzerland g0010 Glossary hypogonadism Decreased or non-existent hormone secretion

More information

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)? Pharmacy Prior Authorization AETA BETTER HEALTH KETUCK Growth Hormone (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and

More information

PRADER-WILLI SYNDROME HOWARD WONG 3UU PER. 6 GENETICS SBS11QHG2 #24

PRADER-WILLI SYNDROME HOWARD WONG 3UU PER. 6 GENETICS SBS11QHG2 #24 PRADER-WILLI SYNDROME HOWARD WONG 3UU PER. 6 GENETICS SBS11QHG2 #24 PHYSIOLOGY Fig. 1 Fig. 2 Prader-Willi Syndrome affects both the physical and mental state of a person, starting from birth until the

More information

Effects of Growth Hormone Treatment on Height, Weight, and Obesity in Taiwanese Patients with Prader-Willi Syndrome

Effects of Growth Hormone Treatment on Height, Weight, and Obesity in Taiwanese Patients with Prader-Willi Syndrome ORIGINAL ARTICLE Effects of Growth Hormone Treatment on Height, Weight, and Obesity in Taiwanese Patients with Prader-Willi Syndrome Hsiang-Yu Lin,,3, Shuan-Pei Lin,,3,, Li-Ping Tsai 5, Mei-Chyn Chao 6,

More information

Danielius Serapinas*

Danielius Serapinas* e - ISSN - 2349-8005 INTERNATIONAL JOURNAL OF ADVANCES IN CASE REPORTS Journal homepage: www.mcmed.us/journal/ijacr PRADER -WILLI SYNDROME : CASE REPORT AND LITERATURE REVIEW Danielius Serapinas* Mykolas

More information

MOLECULAR MARKERS FOR DIAGNOSIS OF PRADER-WILLI SYNDROME IN THAI PATIENTS BY FISH

MOLECULAR MARKERS FOR DIAGNOSIS OF PRADER-WILLI SYNDROME IN THAI PATIENTS BY FISH MOLECULAR MARKERS FOR PWS IN THAI PATIENTS MOLECULAR MARKERS FOR DIAGNOSIS OF PRADER-WILLI SYNDROME IN THAI PATIENTS BY FISH Sirilak Wiriyaukaradecha 1, Pimpicha Patmasiriwat 1, Pornswan Wasant 2 and Pornsri

More information

Information leaflet for patients and families. Uniparental Disomy (UPD)

Information leaflet for patients and families. Uniparental Disomy (UPD) Information leaflet for patients and families Uniparental Disomy (UPD) What are genes and chromosomes? Our genes are the unique set of instructions inside every cell of our body which make each of us an

More information

PRADER WILLY S SYNDROME DIAGNOSED IN EXTREMELY OBESE FEMALE ADOLESCENT

PRADER WILLY S SYNDROME DIAGNOSED IN EXTREMELY OBESE FEMALE ADOLESCENT Snežana Lešović 1 PRADER WILLY S SYNDROME DIAGNOSED IN EXTREMELY OBESE FEMALE ADOLESCENT Introduction: Nutritional obesity is the most common cause of obesity (95%) in childhood and adolescence. Morbid

More information

American Journal of Medical Genetics 91: (2000)

American Journal of Medical Genetics 91: (2000) American Journal of Medical Genetics 91:298 304 (2000) Phenotypic Heterogeneity of Growth and Psychometric Intelligence in Prader-Willi Syndrome: Variable Expression of a Contiguous Gene Syndrome or Parent

More information

How to approach a child with growth concern

How to approach a child with growth concern How to approach a child with growth concern Alaa Al Nofal, MD Assistant Professor of Pediatrics Pediatric Endocrinology Sanford Children Specialty Clinic Nothing to disclose Disclosure Objectives To understand

More information

Prader-Willi Syndrome: an underrecognized

Prader-Willi Syndrome: an underrecognized www.jpnim.com Open Access eissn: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2018;7(1):e070107 doi: 10.7363/070107 Received: 2017 Aug 06; revised: 2017 Aug 24; accepted: 2017 Aug

More information

Basic Facts About PWS:

Basic Facts About PWS: Phone: 800-926-4797 or 941-312-0400 Your membership provides this website - Join Today! Basic Facts About PWS: A Diagnosis and Reference Guide for Physicians and Other Health Professionals What is Prader-Willi

More information

Appendix 1: Syndrome-Specific Growth Charts

Appendix 1: Syndrome-Specific Growth Charts Appendix 1: Syndrome-Specific Growth Charts Figure A1.1 Height centiles for girls with untreated Turner syndrome aged 1 20 years. The gray-shaded area represents the 3rd to 97th centiles for normal girls.

More information

ISSN CHROMOSOME STUDY IN SUSPECTED CASES OF TURNER S SYNDROME FROM JAMMU REGION OF JAMMU & KASHMIR

ISSN CHROMOSOME STUDY IN SUSPECTED CASES OF TURNER S SYNDROME FROM JAMMU REGION OF JAMMU & KASHMIR J. Adv. Zool. 2018: 39(1): 32-36 ISSN-0253-7214 CHROMOSOME STUDY IN SUSPECTED CASES OF TURNER S SYNDROME FROM JAMMU REGION OF JAMMU & KASHMIR Wahied Khawar Balwan and Neelam Saba *Department of Zoology,

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on the Approach to Pediatric Anemia and Pallor. These podcasts are designed to give medical students an overview of key

More information

Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion

Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion Original article http://dx.doi.org/10.6065/apem.2015.20.1.40 Ann Pediatr Endocrinol Metab 2015;20:40-45 Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion Aram Yang, MD,

More information

GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK

GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK Overview GH therapy Indications Specific advantages Extra precautions Case scenarios without

More information

and LHRH Analog Treatment in

and LHRH Analog Treatment in Endocrine Journal 1996, 43 (Suppl), S13-S17 Combined GH Short Children and LHRH Analog Treatment in TosHIAKI TANAKA***, MARL SATOH**, AND ITSURo HIBI* *Division of Endocrinology & Metabolism, National

More information

A s part of a population based study of Prader-Willi

A s part of a population based study of Prader-Willi 926 LETTER TO JMG Relationship between clinical and genetic diagnosis of Prader-Willi syndrome J Whittington, A Holland, T Webb, J Butler, D Clarke, H Boer... J Med Genet 2002;39:926 932 Key points The

More information

A s part of a population based study of Prader-Willi

A s part of a population based study of Prader-Willi 926 LETTER TO JMG Relationship between clinical and genetic diagnosis of Prader-Willi syndrome J Whittington, A Holland, T Webb, J Butler, D Clarke, H Boer... Key points J Med Genet 2002;39:926 932 The

More information

A clinical follow-up of 35 Brazilian patients with Prader- Willi Syndrome

A clinical follow-up of 35 Brazilian patients with Prader- Willi Syndrome DOI:10.6061/clinics/2012(08)11 CLINICAL SCIENCE A clinical follow-up of 35 Brazilian patients with Prader- Willi Syndrome Caio Robledo D Angioli Costa Quaio, I Tatiana Ferreira de Almeida, I Lilian Maria

More information

D own s syndrome (DS) is the most common chromosomal

D own s syndrome (DS) is the most common chromosomal 97 ORIGINAL ARTICLE Growth charts for Down s syndrome from birth to 18 years of age Å Myrelid, J Gustafsson, B Ollars, G Annerén... See end of article for authors affiliations... Correspondence to: Dr

More information

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

Lab Activity 36. Principles of Heredity. Portland Community College BI 233 Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of

More information

Pubertal Development in Japanese Boys

Pubertal Development in Japanese Boys Clin Pediatr Endocrinol 1993; (SuPP13): 7-14 Copyright (C)1993 by The Japanese Society for Pediatric Endocrinology Pubertal Development in Japanese Boys Kenji Fujieda, M.D., Ph. D. Department of Pediatrics,

More information

Growth hormone supplement treatment reduces the surgical risk for Prader Willi Syndrome patients

Growth hormone supplement treatment reduces the surgical risk for Prader Willi Syndrome patients DOI 10.1007/s00586-011-2110-1 CASE REPORT Growth hormone supplement treatment reduces the surgical risk for Prader Willi Syndrome patients Yutaka Nakamura Toshiro Nagai Takahiro Iida Satoru Ozeki Yutaka

More information

First Name. Specialty: Fax. First Name DOB: Duration:

First Name. Specialty: Fax. First Name DOB: Duration: Prescriber Information Last ame: First ame DEA/PI: Specialty: Phone - - Fax - - Member Information Last ame: First ame Member ID umber DOB: - - Medication Information: Drug ame and Strength: Diagnosis:

More information

Epigenetics and Chromatin Remodeling

Epigenetics and Chromatin Remodeling Epigenetics and Chromatin Remodeling Bradford Coffee, PhD, FACMG Emory University Atlanta, GA Speaker Disclosure Information Grant/Research Support: none Salary/Consultant Fees: none Board/Committee/Advisory

More information

Origin of Uniparental Disomy 15 in Patients With Prader-Willi or Angelman Syndrome

Origin of Uniparental Disomy 15 in Patients With Prader-Willi or Angelman Syndrome American Journal of Medical Genetics 94:249 253 (2000) Origin of Uniparental Disomy 15 in Patients With Prader-Willi or Angelman Syndrome Cintia Fridman* and Célia P. Koiffmann Department of Biology, Institute

More information

Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka

Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka Growth hormone therapy for short stature in adolescents Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka K K K Gamage,

More information

hypothyroidism Growth in early treated congenital ORIGINAL ARTICLES

hypothyroidism Growth in early treated congenital ORIGINAL ARTICLES 464 Archives of Disease in Childhood 1994; 70: 464-468 ORIGINAL ARTICLES Institute of Child Health, London D B Grant Correspondence to: Dr D B Grant, Hospital for Sick Children, Great Ormond Street, London

More information

Request for Prior Authorization Growth Hormone (Norditropin

Request for Prior Authorization Growth Hormone (Norditropin Request for Prior Authorization Growth Hormone (Norditropin, Nutropin/AQ ) Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for Growth Hormone require a

More information

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.

More information

Orthopedic and Surgical Features in Patients with Prader Willi Syndrome

Orthopedic and Surgical Features in Patients with Prader Willi Syndrome Orthopedic and Surgical Features in Patients with Prader Willi Syndrome Vlad David, Alexandra Pal Victor Babes University of Medicine and Pharmacy Timisoara Louis Turcanu Emergency Children s Hospital

More information

2. Is the request for Humatrope? Y N [If no, skip to question 6.]

2. Is the request for Humatrope? Y N [If no, skip to question 6.] Pharmacy Prior Authorization AETA BETTER HEALTH FLORIDA Growth Hormone Agents This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date.

More information

Rachel Schmitt and Lesley Powell

Rachel Schmitt and Lesley Powell Prader-Willi Syndrome Rachel Schmitt and Lesley Powell Also Known As Prader-Labhart-Willi Syndrome and Polysardia. Definition Prader-Willi Syndrome is a rare genetic disorder characterised by symptoms

More information

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents Revised April 2014 Growth

More information

HHS Public Access Author manuscript Am J Med Genet. Author manuscript; available in PMC 2017 July 03.

HHS Public Access Author manuscript Am J Med Genet. Author manuscript; available in PMC 2017 July 03. Clinical and Cytogenetic Survey of 39 Individuals With Prader- Labhart-Willi Syndrome Merlin G. Butler, F. John Meaney, and Catherine G. Palmer Division of Genetics, Department of Pediatrics, Vanderbilt

More information

Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy

Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy Original Paper Horm Res 2000;53:185 192 Received: December 22, 1999 Accepted after revision: June 14, 2000 Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with

More information

Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome

Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome Bar et al. Orphanet Journal of Rare Diseases (2017) 12:118 DOI 10.1186/s13023-017-0673-6 RESEARCH Open Access Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome

More information

The science behind igro

The science behind igro The science behind igro igro is an interactive tool that can help physicians evaluate growth outcomes in patients receiving growth hormone (GH) treatment. These pages provide an overview of the concepts

More information

Prader-Willi syndrome: a single center s experience

Prader-Willi syndrome: a single center s experience Original article pissn 1738-1061 eissn 2092-7258 Korean J Pediatr Prader-Willi syndrome: a single center s experience in Korea Yea Ji Kim, MD 1, Chong Kun Cheon, MD, PhD 1,2,3 1 Department of Pediatrics,

More information

Submicroscopic Deletion in Cousins With Prader-Willi Syndrome Causes a Grandmatrilineal Inheritance Pattern: Effects of Imprinting

Submicroscopic Deletion in Cousins With Prader-Willi Syndrome Causes a Grandmatrilineal Inheritance Pattern: Effects of Imprinting American Journal of Medical Genetics 92:19 24 (2000) Submicroscopic Deletion in Cousins With Prader-Willi Syndrome Causes a Grandmatrilineal Inheritance Pattern: Effects of Imprinting Jeffrey E. Ming,

More information

Prader-Willi syndrome (PWS), described by Prader, Willi, and Labhart in 1956, is

Prader-Willi syndrome (PWS), described by Prader, Willi, and Labhart in 1956, is GROWTH HORMONE IMPROVES MOBILITY AND BODY COMPOSITION IN INFANTS AND TODDLERS WITH PRADER-WILLI SYNDROME AARON L. CARREL, MD, VICTORIA MOERCHEN, PHD, PT, SUSAN E. MYERS, MD, M. TRACY BEKX, MD, BARBARA

More information

CYTOGENETICS Dr. Mary Ann Perle

CYTOGENETICS Dr. Mary Ann Perle CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott Seven cases of intellectual disability analysed by genomewide SNP analysis Rodney J. Scott Ability to interrogate Genomic Material ~1930 Crude analyses 2012 Highly precise analyses A (very) brief history

More information

Comment. Prader-Willi syndrome (PWS) remains a complex. Treatment Strategies to Normalize Growth, Weight and Body Composition in Prader-Willi Syndrome

Comment. Prader-Willi syndrome (PWS) remains a complex. Treatment Strategies to Normalize Growth, Weight and Body Composition in Prader-Willi Syndrome Comment Treatment Strategies to Normalize Growth, Weight and Body Composition in Prader-Willi Syndrome URS EIHOLZER Foundation Growth Puberty Adolescence, Zurich, Switzerland Prader-Willi syndrome (PWS)

More information

4/23/2015. Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management. Conflict of Interest. Objectives THANK YOU!

4/23/2015. Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management. Conflict of Interest. Objectives THANK YOU! Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management Kent Reifschneider, MD CHKD / EVMS Norfolk, VA Conflict of Interest Speaker bureau and advisor for Pfizer Board member of The

More information

Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults

Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults Received: 6 July 2017 Revised: 1 September 2017 Accepted: 6 September 2017 DOI: 10.1111/cge.13142 ORIGINAL ARTICLE Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

HHS Public Access Author manuscript Genet Med. Author manuscript; available in PMC 2017 June 05.

HHS Public Access Author manuscript Genet Med. Author manuscript; available in PMC 2017 June 05. Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey Merlin G. Butler, MD, PhD 1, Ann M. Manzardo, PhD 1, Janalee Heinemann, MSW 2, Carolyn Loker 2,

More information

Obesity in Children. JC Opperman

Obesity in Children. JC Opperman Obesity in Children JC Opperman Definition The child too heavy for height or length Obvious on inspection 10 to 20% over desirable weight = overweight More than 20% = obese Use percentile charts for the

More information

Start small, think big: Growth monitoring, genetic analysis, treatment and quality of life in children with growth disorders Stalman, S.E.

Start small, think big: Growth monitoring, genetic analysis, treatment and quality of life in children with growth disorders Stalman, S.E. UvA-DARE (Digital Academic Repository) Start small, think big: Growth monitoring, genetic analysis, treatment and quality of life in children with growth disorders Stalman, S.E. Link to publication Citation

More information

Aetna Better Health of Virginia

Aetna Better Health of Virginia Genotropin Nutropin Serostim Zomacton Humatrope Omnitrope Zorbtive somatropin Norditropin Saizen General Criteria for Approval: Omnitrope vial formulation is the preferred Growth Hormone product; consideration

More information

Development of disease-specific growth charts in Turner syndrome and Noonan syndrome

Development of disease-specific growth charts in Turner syndrome and Noonan syndrome Review article https://doi.org/10.6065/apem.2017.22.4.240 Ann Pediatr Endocrinol Metab 2017;22:240-246 Development of disease-specific growth charts in Turner syndrome and Noonan syndrome Tsuyoshi Isojima,

More information

CIGNA HealthCare Prior Authorization Form - Growth Hormone Medications -

CIGNA HealthCare Prior Authorization Form - Growth Hormone Medications - Pharmacy Services Phone: (800)244-6224 Fax: (800)390-9745 CIGNA HealthCare Prior Authorization Form - Growth Hormone Medications - Notice: Failure to complete this form in its entirety may result in delayed

More information

World Health Organization Growth Standards. BC Training Module PowerPoint Speaking Notes

World Health Organization Growth Standards. BC Training Module PowerPoint Speaking Notes World Health Organization Growth Standards BC Training Module PowerPoint Speaking Notes May 30, 2011 British Columbia WHO Growth Chart Training June 2011 Page 1 PowerPoint Speaking Notes Slide 1 Title

More information

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea Clin Pediatr Endocrinol 1996; 5(2), 61-66 Copyright (C) 1996 by The Japanese Society for Pediatric Endocrinology Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea Toshihisa Okada, Soroku

More information

This CNE activity is supported by an educational grant from Novo Nordisk Inc.

This CNE activity is supported by an educational grant from Novo Nordisk Inc. This CNE activity is supported by an educational grant from Novo Nordisk Inc. Objectives Differentiate between normal growth variants and growth variants that are linked to a disorder Describe the process

More information

Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature) Anthony D, Stevens A

Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature) Anthony D, Stevens A Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature) Anthony D, Stevens A Record Status This is a critical abstract of an economic

More information

CHROMOSOMAL NUMERICAL ABERRATIONS INSTITUTE OF BIOLOGY AND MEDICAL GENETICS OF THE 1 ST FACULTY OF MEDICINE

CHROMOSOMAL NUMERICAL ABERRATIONS INSTITUTE OF BIOLOGY AND MEDICAL GENETICS OF THE 1 ST FACULTY OF MEDICINE CHROMOSOMAL NUMERICAL ABERRATIONS INSTITUTE OF BIOLOGY AND MEDICAL GENETICS OF THE 1 ST FACULTY OF MEDICINE CHROMOSOMAL ABERRATIONS NUMERICAL STRUCTURAL ANEUPLOIDY POLYPLOIDY MONOSOMY TRISOMY TRIPLOIDY

More information

Critical Growth Phases for Adult Shortness

Critical Growth Phases for Adult Shortness American Journal of Epidemiology Copyright 2000 by The Johns Hopkins University chool of Hygiene and Public Health All rights reserved Vol. 2, o. 2 Printed in U..A. Critical Growth Phases for Adult hortness

More information

Case 1B. 46,XY,-14,+t(14;21)

Case 1B. 46,XY,-14,+t(14;21) Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short

More information

Case Report Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum

Case Report Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum Hindawi Case Reports in Endocrinology Volume 2017, Article ID 4271978, 4 pages https://doi.org/10.1155/2017/4271978 Case Report Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and

More information

Special Needs Growth Charts

Special Needs Growth Charts Special Needs Growth Charts WIC staff are encouraged to review the online module entitled The CDC Growth Charts for Children with Special Health Care Needs. The CDC module was revised by the University

More information

Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome

Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome van Nieuwpoort et al. International Journal of Pediatric Endocrinology (2018) 2018:1 DOI 10.1186/s13633-018-0055-4 RESEARCH Open Access Body composition, adipokines, bone mineral density and bone remodeling

More information

TEXAS MEDICAID Clinical Edit Prior Authorization Growth Hormones: HUMATROPE, NUTROPIN AQ, OMNITROPE, SAIZEN

TEXAS MEDICAID Clinical Edit Prior Authorization Growth Hormones: HUMATROPE, NUTROPIN AQ, OMNITROPE, SAIZEN TEXAS MEDICAID Clinical Edit Prior Authorization Growth Hormones: HUMATROPE, NUTROPIN AQ, OMNITROPE, SAIZEN STEP 1: CLEARLY PRINT AND COMPLETE TO EXPEDITE PROCESSING Date: Prescriber First & Last Name:

More information

Intrauterine Growth Retardation or Small Gestational Age. Series N.14

Intrauterine Growth Retardation or Small Gestational Age. Series N.14 Intrauterine Growth Retardation or Small Gestational Age Series N.14 Patient s Guide Average Readability Leaflet Intrauterine Growth Retardation- Series 14 (Revised August 2006) This leaflet was produced

More information

Management of Psychosis in an Adult Cohort of Patients with Prader-Willi Syndrome

Management of Psychosis in an Adult Cohort of Patients with Prader-Willi Syndrome Management of Psychosis in an Adult Cohort of Patients with Prader-Willi Syndrome Joanna MacLean Home for the Summer Program June 7 th July 13 th Stonewall, MB Supervisor: Dr. Gregory Pinniger Abstract

More information

Feeding Disorders and Growth in Williams Syndrome

Feeding Disorders and Growth in Williams Syndrome Feeding Disorders and Growth in Williams Syndrome Sharon M. Greis M.A., CCC/SLP BRS-S and Paige Kaplan M.B.B.Ch. Williams Syndrome Clinic The Children s Hospital of Philadelphia Pediatric Feeding & Swallowing

More information

Growth Hormone Therapy

Growth Hormone Therapy Growth Hormone Therapy Policy Number: Original Effective Date: MM.04.011 05/21/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 05/23/2014 Section: Prescription Drugs Place(s)

More information

Circle Yes or No Y N. [If yes, skip to question 30.] 2. Is this request for a child? Y N. [If no, skip to question 20.]

Circle Yes or No Y N. [If yes, skip to question 30.] 2. Is this request for a child? Y N. [If no, skip to question 20.] 05/20/2015 Prior Authorization MERC CARE PLA (MEDICAID) Growth Hormone (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and

More information

Prader Willi syndrome with a karyotype 47,XY,+min(15)(pter->q11.1:) and maternal UPD 15 case report plus review of similar cases

Prader Willi syndrome with a karyotype 47,XY,+min(15)(pter->q11.1:) and maternal UPD 15 case report plus review of similar cases European Journal of Medical Genetics 48 (2005) 175 181 www.elsevier.com/locate/ejmg Case report Prader Willi syndrome with a karyotype 47,XY,+min(15)(pter->q11.1:) and maternal UPD 15 case report plus

More information

X/00/$03.00/0 Vol. 85, No. 11 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society

X/00/$03.00/0 Vol. 85, No. 11 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society 0021-972X/00/$03.00/0 Vol. 85, No. 11 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Prediction of Long-Term Response to Recombinant Human

More information

Original. Tsuyoshi Isojima 1), 2), 3), Tomonobu Hasegawa 1), 4), Susumu Yokoya 1), 5) 1), 6) and Toshiaki Tanaka

Original. Tsuyoshi Isojima 1), 2), 3), Tomonobu Hasegawa 1), 4), Susumu Yokoya 1), 5) 1), 6) and Toshiaki Tanaka 2017, 64 (9), 851-858 Original The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation

More information

World Health Organization Growth Standards. First Nations and Inuit Health Alberta Region: Training Module May 2011

World Health Organization Growth Standards. First Nations and Inuit Health Alberta Region: Training Module May 2011 World Health Organization Growth Standards First Nations and Inuit Health Alberta Region: Training Module May 2011 Acknowledgements First Nation and Inuit Health Alberta Region would like to thank the

More information

Instructor s Manual Chapter 28 Endocrine Alterations. 1. Which of the following is an example of a negative feedback system?

Instructor s Manual Chapter 28 Endocrine Alterations. 1. Which of the following is an example of a negative feedback system? 1 Instructor s Manual Chapter 28 Endocrine Alterations Answers to Study Questions 1. Which of the following is an example of a negative feedback system? a. Hypothalamus secretes ACTH, stimulating the anterior

More information

NEW WHO GROWTH CURVES Why in QATAR? Ashraf T Soliman MD PhD FRCP

NEW WHO GROWTH CURVES Why in QATAR? Ashraf T Soliman MD PhD FRCP NEW WHO GROWTH CURVES Why in QATAR? Ashraf T Soliman MD PhD FRCP Qatar CIA World Factbook demographic statistics. Population : 928,635 (July 2008 est.) Age structure : 0-14 years: 23.7% (male 104,453;

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other SOMATROPIN HUMATROPE GENOTROPIN NORDITROPIN NORDITROPIN FLEXPRO NORDITROPIN NORDIFLEX NUTROPIN NUTROPIN AQ OMNITROPE SAIZEN ZOMACTON 02824 BRAND ZORBTIVE BRAND SEROSTIM

More information

High resolution melting for methylation analysis

High resolution melting for methylation analysis High resolution melting for methylation analysis Helen White, PhD Senior Scientist National Genetics Reference Lab (Wessex) Why analyse methylation? Genomic imprinting In diploid organisms somatic cells

More information

Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype

Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype J Med Genet 1993; 30: 761-766 Department of Clinical Genetics, University Hospital Dijkzigt, Erasmus University, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. L B A de Vries E Wesby-van Swaay

More information

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None Why is my body not changing? Murthy Korada Pediatrician, Pediatric Endocrinologist Ridge Meadows Hospital Surrey Memorial Hospital None Conflicts of interest Overview Overview of normal pubertal timing

More information

Analysis of the Sex-determining Region of the Y Chromosome (SRY) in a Case of 46, XX True Hermaphrodite

Analysis of the Sex-determining Region of the Y Chromosome (SRY) in a Case of 46, XX True Hermaphrodite Clin Pediatr Endocrinol 1994; 3(2): 91-95 Copyright (C) 1994 by The Japanese Society for Pediatric Endocrinology Analysis of the Sex-determining Region of the Y Chromosome (SRY) in a Case of 46, XX True

More information

Feeding the Small for Gestational Age Infant. Feeding the Small for Gestational Age Infant

Feeding the Small for Gestational Age Infant. Feeding the Small for Gestational Age Infant Feeding the Small for Gestational Age Infant Feeding the Small for Gestational Age Infant What s the right strategy? Infants born small-for-gestational age (SGA) are at higher risk for adult diseases.

More information

Obesity: Physiology, Health and Diseases 5 July Genetic of Obesity

Obesity: Physiology, Health and Diseases 5 July Genetic of Obesity Obesity: Physiology, Health and Diseases 5 July 2017 Genetic of Obesity Voraluck Phatarakijnirund, MD. Division of Endocrinology Department of Pediatrics Phramongkutklao Hospital Phramongkutklao Colleague

More information

Linear Growth Assessment: Evaluation and Causes and Treatment of Growth Failure

Linear Growth Assessment: Evaluation and Causes and Treatment of Growth Failure Linear Growth Assessment: Evaluation and Causes and Treatment of Growth Failure Terri H. Lipman PhD, CRNP, FAAN University of Pennsylvania, School of Nursing Children s Hospital of Philadelphia Growth

More information

brief report Genetics IN Medicine 243

brief report Genetics IN Medicine 243 April 2006 Vol. 8 No. 4 brief report C-reactive protein levels in subjects with Prader-Willi syndrome and obesity Merlin G. Butler, MD, PhD 1, Douglas C. Bittel, PhD 1, Nataliya Kibiryeva, MD 1, and Uttam

More information

MLPA SAMPLES USER GUIDE

MLPA SAMPLES USER GUIDE MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple

More information

CommonKnowledge. Pacific University. Peter Bodmer Pacific University. Summer

CommonKnowledge. Pacific University. Peter Bodmer Pacific University. Summer Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects Summer 8-8-2015 Human chorionic gonadotropin (hcg) for Improved Virility without Negative

More information

Hypothesis: A specific pathway can be identified between genetic characteristics and

Hypothesis: A specific pathway can be identified between genetic characteristics and Hypothesis: A specific pathway can be identified between genetic characteristics and behaviour profiles in Prader-Willi syndrome via cognitive, environmental and physiological mechanisms ABSTRACT Background

More information

Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region

Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region 792 Letters Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief No 144. Online. Hum Mutat

More information

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Sarah South, PhD, FACMG Medical Director, ARUP Laboratories Department of Pediatrics and Pathology University

More information